News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. ties billions in unpaid UN dues to quick cost cuts and limits on Chinese influence.
  • UAE exits OPEC and OPEC+ while Iraq affirms continued membership, adding oil-market uncertainty.
  • Surging crude lifts soybean oil to three-year highs, improving margins and earnings outlook for Bunge and ADM.
  • Major U.S. firms report resilience but warn higher oil and packaging costs will pressure margins.
  • USGS estimates about 2.3 million tonnes of recoverable lithium in the Appalachians, potentially reducing U.S. import reliance.
  • Joby begins week-long eVTOL demonstration flights across New York under an FAA pilot program to validate performance and acoustics.

Latest Articles

Economists Still Expect Fed to Delay Rate Cuts Until September Despite Market Odds

Economists Still Expect Fed to Delay Rate Cuts Until September Despite Market Odds

Economists surveyed in late March anticipate the Federal Reserve will keep the federal funds rate unchanged through the summer and only consider trimming policy in September, even as financial markets increasingly rule out cuts this year and factor in a non-negligible chance of a rate hike amid a worsening Middle East conflict and higher oil prices…

Virtuix Delivers Omni One to the U.S. Marine Corps

Virtuix Delivers Omni One to the U.S. Marine Corps

Virtuix Inc. announced the delivery of its Omni One omni-directional treadmill system to the U.S. Marine Corps Training and Education Command for evaluation in warfighter training and mission planning. This follows previous deployments at other branches of the U.S. military, highlighting growing adoption of Virtuix's full-body VR movement technolog…

Wave Life Shares Drop 30% After Positive Phase 1 INLIGHT Data for WVE-007

Wave Life Shares Drop 30% After Positive Phase 1 INLIGHT Data for WVE-007

Wave Life Sciences reported interim Phase 1 INLIGHT data showing a single 240 mg dose of WVE-007 produced a placebo-adjusted 14% reduction in visceral fat at six months, along with improvements in visceral fat-to-muscle ratio, waist circumference, and lean mass. The company also reported sustained reductions in Serum Activin E and tolerability up t…

Israel's Plan to Push a 'Buffer Zone' to the Litani Revives History of Invasions and Raises Fears of Occupation in Lebanon

Israel's Plan to Push a 'Buffer Zone' to the Litani Revives History of Invasions and Raises Fears of Occupation in Lebanon

Israel has ordered residents south of Lebanon’s Litani River to evacuate and has moved to fortify and partially control the area, saying it is establishing a buffer zone to prevent attacks by Hezbollah. The measures - including destruction of bridges, house demolitions and the deployment of thousands of troops - have renewed Lebanese fears of occup…

Winnebago After the Dip: A Mid-Term Swing Trade on Oversold RV Exposure

Winnebago After the Dip: A Mid-Term Swing Trade on Oversold RV Exposure

Winnebago (WGO) pulled back sharply after mixed Q2 FY2026 results driven by falling unit volumes. The stock is trading near support, shows oversold technicals and still generates healthy free cash flow and a meaningful dividend. This is an actionable mid-term swing trade: enter at $33.00, stop at $30.00, target $42.00 over ~45 trading days, with cl…

Blue Bird: Pricing, Backlog Visibility, and a Trade to Ride H2 Momentum

Blue Bird: Pricing, Backlog Visibility, and a Trade to Ride H2 Momentum

Blue Bird's recent beat-and-raise performance, attractive cash generation and reasonable valuation metrics give the stock a clear risk/reward for a mid-term trade. Pricing actions and a durable backlog should give management visibility into a stronger second half; the proposed plan targets a measured upside while limiting downside with a defined st…

Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors

Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors

Plus Therapeutics, a clinical-stage healthcare company focused on precision diagnostics and radiopharmaceuticals for CNS cancers, has appointed Ron Andrews, a seasoned diagnostics and molecular diagnostics leader, to its Board of Directors. Andrews' extensive experience and network in diagnostics are expected to bolster the advancement and commerci…

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Medicus Pharma Ltd. announced robust Phase 2 clinical trial results for its SkinJect immuno-oncology product targeting basal cell carcinoma, achieving an 80% overall response rate in the 200µg cohort at Day 57. The company also detailed plans to implement an agentic AI-enabled platform to optimize drug development. Highlights include presentation b…

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

Wave Life Sciences announces encouraging 6-month data from the Phase 1 portion of its INLIGHT trial evaluating WVE-007, an investigational RNAi therapeutic for obesity. A single 240 mg dose demonstrated significant reductions in visceral fat and waist circumference, preservation of lean muscle, and a favorable safety profile. These results surpass …

Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update

Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update

Cognition Therapeutics reports year-end 2025 financial results and significant clinical updates, including completion of enrollment in a Phase 2 Alzheimer's study, positive Phase 2 data in dementia with Lewy bodies (DLB) psychosis, initiation of an expanded access program, and plans for a mid-2026 FDA meeting to align on registrational trials for z…

Luana Savings Bank Selects nCino to Unify and Transform Its Commercial and Agricultural Lending Operations

Luana Savings Bank Selects nCino to Unify and Transform Its Commercial and Agricultural Lending Operations

nCino, a leading provider of intelligent banking solutions, announced that Luana Savings Bank, a well-established community bank in Iowa, has selected nCino's platform to transform and unify its commercial and agricultural lending processes. The partnership aims to replace manual, redundant tasks with automated, streamlined workflows to improve ope…

Hillman Recognized by REDI Cincinnati with James A. Wuenker Growth Award for Forest Fair Mall Redevelopment Project

Hillman Recognized by REDI Cincinnati with James A. Wuenker Growth Award for Forest Fair Mall Redevelopment Project

Hillman Solutions Corp., a leading provider of hardware-related products, has been awarded the 2026 James A. Wuenker Growth Award by REDI Cincinnati in recognition of its redevelopment project at the Forest Fair Mall site. The project consolidates several Cincinnati-area operations into a new 715,000-square-foot facility, aiming to boost collaborat…

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

BrainsWay Ltd. announced the completion of an additional $6 million milestone-based convertible loan investment in Neurolief Ltd., triggered by the FDA Premarket Approval of Neurolief's Proliv™Rx device for major depressive disorder (MDD). This investment follows BrainsWay's August 2025 strategic partnership with Neurolief aimed at expanding innova…

RVYL Shareholder Meeting Continued to April 1, with 99% of Votes Cast in Favor of Roundtable Merger

RVYL Shareholder Meeting Continued to April 1, with 99% of Votes Cast in Favor of Roundtable Merger

RYVYL Inc. announced that 99% of votes cast at its Special Shareholder Meeting support the planned merger with RTB Digital, Inc. The company needs just an additional 5% vote to exceed 50% of outstanding shares to complete the merger. The meeting was adjourned and will reconvene virtually on April 1, 2026, to finalize votes and merger approval. The …

Economists Say BoE Will Stand Pat at 3.75% as Markets Price in More Hikes

Economists Say BoE Will Stand Pat at 3.75% as Markets Price in More Hikes

A narrow majority of economists surveyed expect the Bank of England to keep Bank Rate at 3.75% through the remainder of the year, reversing forecasts for near-term cuts. While energy-driven inflation risks from the U.S. and Israeli conflict with Iran have forced many forecasters to lift inflation and year-end rate projections, most economists do no…

Morgan Stanley Downgrades Redeia, Cites Near-Zero EPS Growth to 2028

Morgan Stanley Downgrades Redeia, Cites Near-Zero EPS Growth to 2028

Morgan Stanley lowered its rating on Redeia to equal-weight from overweight and cut the price target from €18 to €15 after the company's strategic plan to 2029 implied slower RAB and net income growth than expected. The bank sees virtually no EPS expansion to 2028 once hybrid issuances are accounted for, raises the Spanish transmission WACC assumpt…